Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 93

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 93
---
 the healthcare industry’s current practices and could
have an adverse effect on NewGenIvf’s business, financial condition, results of operations and growth prospects.

Advertising or offering of gender selection services in certain jurisdictions in which NewGenIvf operates could expose the Company and its directors and executive officers to significant legal and regulatory risks, including potential penalties.

The marketing or provision
of gender selection services in certain jurisdictions in which we operate is subject to stringent legal restrictions. In particular, in
Hong Kong, under the Human Reproductive Technology Ordinance (Cap. 561 of the Laws of Hong Kong), gender selection for non-medical purposes
is prohibited. Violation of these provisions may result in criminal liability. Any person found guilty of advertising or offering gender
selection services in Hong Kong may, on a first conviction, face a fine of up to HKD 25,000 and imprisonment for up to 6 months. If we,
our representatives, or our sub-contractors inadvertently violate, or are alleged to violate, these laws, we could face significant financial
penalties, reputational harm, and potential legal proceedings. Even if we do not directly market our gender selection services in Hong
Kong, promotional activities conducted by third parties, affiliates, or other associates on our behalf could also expose us to liability
under these laws.

Additionally, increased scrutiny
or enforcement actions by regulatory authorities in the jurisdictions in which we operate, including Hong Kong, could result in adverse
publicity, increased compliance costs, and significant disruption of our business operations in the region. As a result, any failure to
comply with applicable laws and regulations related to gender selection services could have a material adverse effect on our business,
financial condition, and results of operations.

Significant tariffs or other restrictions imposed on imports by the U.S. and related countermeasures taken by impacted countries could have a material adverse effect on our operations and financial results.

If significant tariffs or
other restrictions are imposed on imports by the U.S. and related countermeasures are taken by foreign countries, our business, including
results of operations, cash flows and financial condition, may be adversely affected. In January 2025, during the initial days of U.S.
President Trump’s second term, the U.S. announced the imposition of additional substantial tariffs on imports from various countries,
including China, Canada and Mexico, and the subject countries have imposed or indicated their intention to impose counter measures. In
February 2025, the U.S. imposed tariffs of